Leishmaniasis in IBD Patients: Challenges of a Rare Opportunistic Disease.
作者信息
Abreu Candida, Rocha Rafael
机构信息
Serviço de Doenças Infeciosas, Hospital de São joão, Unidade Local de Saúde de São João, Porto, Portugal.
Faculdade de Medicina, Departamento de Medicina, RISE-Health, Universidade do Porto, Porto, Portugal.
出版信息
United European Gastroenterol J. 2025 Jun;13(5):665-666. doi: 10.1002/ueg2.12753. Epub 2025 Jan 8.
Abstract
摘要
相似文献
1
Leishmaniasis in IBD Patients: Challenges of a Rare Opportunistic Disease.炎症性肠病患者中的利什曼病：一种罕见机会性疾病的挑战
United European Gastroenterol J. 2025 Jun;13(5):665-666. doi: 10.1002/ueg2.12753. Epub 2025 Jan 8.
2
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU.炎症性肠病患者的利什曼病：GETECCU的一项全国多中心研究。
United European Gastroenterol J. 2025 Jun;13(5):674-684. doi: 10.1002/ueg2.12740. Epub 2025 Jan 8.
3
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.生物疗法与炎症性肠病患者感染和恶性肿瘤风险：系统评价和网络荟萃分析。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1385-1397.e10. doi: 10.1016/j.cgh.2016.04.039. Epub 2016 May 14.
4
Challenges in IBD Research 2024: Novel Technologies.2024 年炎症性肠病研究面临的挑战：新技术。
Inflamm Bowel Dis. 2024 May 23;30(Suppl 2):S30-S38. doi: 10.1093/ibd/izae082.
5
Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrum.病例报告：播散性利什曼病与类风湿关节炎：应对临床难题。
Front Immunol. 2025 Jun 5;16:1599381. doi: 10.3389/fimmu.2025.1599381. eCollection 2025.
6
Epidemiology of inflammatory bowel disease in Spain. A systematic review.西班牙炎症性肠病的流行病学。一项系统评价。
Rev Esp Enferm Dig. 2001 Jan;93(1):9-20.
7
How Common Is Imported Cutaneous Leishmaniasis in Romania? Two Case Reports.罗马尼亚输入性皮肤利什曼病的发病率如何？两例报告。
Microorganisms. 2025 May 25;13(6):1207. doi: 10.3390/microorganisms13061207.
8
Pancreatic Disorders in Children with Inflammatory Bowel Disease.儿童炎症性肠病相关胰腺疾病。
Medicina (Kaunas). 2021 May 11;57(5):473. doi: 10.3390/medicina57050473.
9
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
10
Malignancy and Inflammatory Bowel Disease (IBD): Incidence and Prevalence of Malignancy in Correlation to IBD Therapy and Disease Activity-A Retrospective Cohort Analysis over 5 Years.恶性肿瘤与炎症性肠病（IBD）：与IBD治疗及疾病活动相关的恶性肿瘤发病率和患病率——一项为期5年的回顾性队列分析
Biomedicines. 2025 Jun 6;13(6):1395. doi: 10.3390/biomedicines13061395.
本文引用的文献
1
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU.炎症性肠病患者的利什曼病：GETECCU的一项全国多中心研究。
United European Gastroenterol J. 2025 Jun;13(5):674-684. doi: 10.1002/ueg2.12740. Epub 2025 Jan 8.
2
(Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review.（重新）引入 TNF 拮抗剂和 JAK 抑制剂治疗既往结核病患者：系统评价。
Clin Microbiol Infect. 2024 Aug;30(8):989-998. doi: 10.1016/j.cmi.2024.04.011. Epub 2024 Apr 23.
3
Leishmania infection in patients with inflammatory bowel disease: Case series and literature review.利什曼原虫感染炎症性肠病患者：病例系列及文献复习。
Gastroenterol Hepatol. 2024 Jan;47(1):82-92. doi: 10.1016/j.gastrohep.2023.04.001. Epub 2023 Apr 13.
4
asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy.接受抗TNF治疗的炎症性肠病患者的无症状感染
Heliyon. 2020 May 8;6(5):e03940. doi: 10.1016/j.heliyon.2020.e03940. eCollection 2020 May.
5
Real-time PCR applications for diagnosis of leishmaniasis.实时聚合酶链反应在利什曼病诊断中的应用。
Parasit Vectors. 2018 May 2;11(1):273. doi: 10.1186/s13071-018-2859-8.
6
Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases).抗肿瘤坏死因子治疗期间的利什曼病：4 例报告及文献复习（另加 28 例）。
Semin Arthritis Rheum. 2013 Oct;43(2):152-7. doi: 10.1016/j.semarthrit.2013.01.006. Epub 2013 Jun 15.
7
Determinants for the development of visceral leishmaniasis disease.内脏利什曼病发病的决定因素。
PLoS Pathog. 2013 Jan;9(1):e1003053. doi: 10.1371/journal.ppat.1003053. Epub 2013 Jan 3.
8
T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?辅助性 T 细胞 1/辅助性 T 细胞 2 与利什曼原虫感染的抗性/易感性：这一范式是否仍然相关？
Front Immunol. 2012 Apr 17;3:80. doi: 10.3389/fimmu.2012.00080. eCollection 2012.
9
Leishmaniasis among organ transplant recipients.器官移植受者中的利什曼病
Lancet Infect Dis. 2008 Mar;8(3):191-9. doi: 10.1016/S1473-3099(08)70043-4.
10
Leishmania and human immunodeficiency virus coinfection: the first 10 years.利什曼原虫与人类免疫缺陷病毒合并感染：头十年
Clin Microbiol Rev. 1997 Apr;10(2):298-319. doi: 10.1128/CMR.10.2.298.
Zotero 插件